TY - JOUR
T1 - Allosteric interactions between muscarinic agonist binding sites and effector sites demonstrated by the use of bisquaternary pyridinium oximes
AU - Kloog, Yoel
AU - Sokolovsky, Mordechai
N1 - Funding Information:
Recent studies exploring the mode of interaction between hisquaternary pyridinium oximes (i.e. HGG-12) and the muscarinic receptors in rat brain suggested that this and related oximes are allosteric inhibitors of the muscarinic receptor (I). These studies, which employed equilibrium as well as kinetic studies with the muscarinic antagonist \[3H\]-N-methyl-4-piperidylb enzilate (\[3H\]-4NMPB), indicated that in the rat cerebral cortex and brain stem these oximes bind to a site distinct from the antagonist binding site (i). It was therefore of interest to examine the effects of HGG-12 on the binding of muscarinic agonists, which reveals unique features not ohserved with antagonists. Thus, the binding of agonists may be expressed as binding to two or three affinity states (as reviewed in (2-5)), which may interconvert for example by treatment with guanyl nucleotides (6-17) or transition metal ions (15, 16, 18, 19). The former convert agonist high-affinity sites to low-affinity sites in rat brain preparations without affecting antagonist binding. This effect is observed in those brain regions which have a relatively large proportion of high affinity binding (e.g. brain stem), while regions enriched in low affinity sites (e.g. brain cortex) show little if any such effect. Interconversion of agonist hinding sites from low-affinity to high-affinity can be induced by treatment with divalent transition metal ions (e.g. Co 2+, Ni 2+) \[13, 15, 16, 19). The effect of the metal * This study was supported by Research Grant DAMD-17-81-C-1225 from the U.S. Army Medical Research Command.
PY - 1985/6/3
Y1 - 1985/6/3
N2 - Agonist binding to muscarinic receptors from rat brain stem and cerebral cortex was studied using bisquaternary pyridinium oximes for detecting possible interactions between agonist binding sites and sites of the effector guanosine 5′ (β, γ-imino) triphosphate (Gpp(NH)p) and Co2+. Pretreatment of either brain stem or cortical homogenates with 200 μM 1-(2-hydroxyiminoethylpyridinium) 1-(3-phenylcarboxypyridinium) dimethylether (HGG-12) reduced the affinity of muscarinic agonists. No change was observed in the relative proportions of high (RH) and low (RL) affinity agonist binding sites. However, the oxime affected the processes of interconversion between these sites. Thus, unlike in control membranes, HGG-12 treated brain stem membranes, Gpp(NH)p could not induce conversion of RH to RL, and in cortical membranes Co2+ could not induce conversion of RL to RH. These results suggest that HGG-12 inactivates a component which is involved in both processes of induced-interconversion. Induced-interconversion between RH and RL was not affected in membranes treated with HGG-12 in the presence of carbamylcholine in concentrations at which mainly RH is occupied by the agonist. The occupation of RH by carbamylcholine protected both RH and RL from the effects of the oxime. The possible role of the molecular events involved is discussed.
AB - Agonist binding to muscarinic receptors from rat brain stem and cerebral cortex was studied using bisquaternary pyridinium oximes for detecting possible interactions between agonist binding sites and sites of the effector guanosine 5′ (β, γ-imino) triphosphate (Gpp(NH)p) and Co2+. Pretreatment of either brain stem or cortical homogenates with 200 μM 1-(2-hydroxyiminoethylpyridinium) 1-(3-phenylcarboxypyridinium) dimethylether (HGG-12) reduced the affinity of muscarinic agonists. No change was observed in the relative proportions of high (RH) and low (RL) affinity agonist binding sites. However, the oxime affected the processes of interconversion between these sites. Thus, unlike in control membranes, HGG-12 treated brain stem membranes, Gpp(NH)p could not induce conversion of RH to RL, and in cortical membranes Co2+ could not induce conversion of RL to RH. These results suggest that HGG-12 inactivates a component which is involved in both processes of induced-interconversion. Induced-interconversion between RH and RL was not affected in membranes treated with HGG-12 in the presence of carbamylcholine in concentrations at which mainly RH is occupied by the agonist. The occupation of RH by carbamylcholine protected both RH and RL from the effects of the oxime. The possible role of the molecular events involved is discussed.
UR - http://www.scopus.com/inward/record.url?scp=0021841169&partnerID=8YFLogxK
U2 - 10.1016/0024-3205(85)90309-1
DO - 10.1016/0024-3205(85)90309-1
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0021841169
SN - 0024-3205
VL - 36
SP - 2127
EP - 2136
JO - Life Sciences
JF - Life Sciences
IS - 22
ER -